Bausch Health Companies Inc. (BHC.TO) Buy,…

Bausch Health Companies Inc. (BHC.TO)

6.57

-0.17 (2.52%)

as of Jun 19, 2026, 8:00:01 pm Market Open.

51 watching

SELL

Kudos to the new executive at delevering and cleaning things up. Inexpensive valuation. Still a lot of debt. A turnaround story. 3% of your portfolio is a bit heavy. Add some diversity. Had a great move. Be cautious.

Wealthica Track your Stocks in your Watch List

DON'T BUY

He won't offer a buy-sell-hold verdict. BHC has done a good reorganization. There's talk of spinning out their eye division. Has a 6.5% EBITDA-to-debt ratio, so there's still some debt. They're still restructuring, so there will be little growth.

DON'T BUY

A turnaround story. They have done a good job stabilizing the company. It has a lot of debt and legal issues to resolve. The debt levels are probably still too high. They are spinning out their eyecare business which is their crown jewel. There is some more work to do before taking a position.

DON'T BUY

Spinning out the eyecare side. Better to go to the US with bigger, safer stocks or one of the ETFs.

DON'T BUY

The old Valent Pharmaceutical company. When it became over-levered it struggled. He thinks there are far better opportunities in the health care space.

BUY ON WEAKNESS

He likes and owns it. It is basically the old broken valiant. He likes the space and he likes the big time drugs. These stocks offer incredible value. His model price is $72.41, 122% upside. Buy it when it comes down again. Buy half on the way in.

DON'T BUY

He gives managements kudos for restructuring the business. They are still heavily indebted. He is looking for valuation with consistent cashflow which this is not. It's not the type of company he looks at.

WATCH

Kudos to the management for selling off businesses and paying down debt. It may be something investor should look at again.

Wealthica Track your Stocks in your Watch List

BUY

If it can continue on volume, it looks very positive. It has built a nice base and it’s worthy of a buy. Support should be around $27. He would aim for the 100 day moving average.

BUY

A covered call He likes covered calls and you can do it with BHC. Write them and take the premium here. BHC has been rangebound, but demographics favour health stocks. However, governments will limit pricing of health services.

DON'T BUY

There's too much debt and not enough growth to pay it off. The stock has sold off as their generic products face new competition.

COMMENT

They still only have a couple products that are growing. Other drugs are in their infancy or not growing. If they're not able to cover debt with free cashflow, you won't see any dividends.

BUY

After a stunning fall from grace, there's been a stunning recovery. FMV is 127% higher than it's currently trading, and it's been there before. Looks like a resurrection.

DON'T BUY

There are better opportunities out there. They meet his criteria except for their debt levels.

TOP PICK

He likes it because nobody likes it. It is former Valiant Pharmaceuticals and trades at 6 times cash-flow. He encourages investors to look beyond its checkered past. It has high quality recurring cash-flows in the contact lens division. Every division is growing organically. It does have a high debt load, but the trajectory of cash flow will elevate that risk. Yield 0%. (Analysts’ price target is $35.39)

Showing 1 to 15 of 16 entries

Bausch Health Companies Inc. (BHC.TO) Frequently Asked Questions

What is Bausch Health Companies Inc. stock symbol?

Bausch Health Companies Inc. is a Canadian stock, trading under the symbol BHC.TO (previously BHC-T on Stockchase) on the Toronto Stock Exchange (BHC-CT). It is usually referred to as TSX:BHC or BHC.TO

Is Bausch Health Companies Inc. a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on BHC.TO (previously BHC-T on Stockchase) on Stockchase. Read the latest expert commentary for Bausch Health Companies Inc..

Is Bausch Health Companies Inc. a good investment or a top pick?

Bausch Health Companies Inc. was recommended as a Top Pick by Steven Ko on 2018-11-30. Read the latest stock experts ratings for Bausch Health Companies Inc..

Why is Bausch Health Companies Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Bausch Health Companies Inc..

Is Bausch Health Companies Inc. worth watching?

Bausch Health Companies Inc. is followed by 51 investors on Stockchase and is a trending stock that is worth watching.

What is Bausch Health Companies Inc. stock price?

On 2026-06-19, Bausch Health Companies Inc. (BHC.TO) stock closed at a price of $6.57.

Most Recent Experts

Rick Rule

Rule Investment Media

Chris Blumas

at Raymond James Investment Counsel Ltd.

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Bausch Health Companies Inc. (BHC.TO)